{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T03:49:09Z","timestamp":1772509749238,"version":"3.50.1"},"reference-count":39,"publisher":"Informa UK Limited","issue":"2","license":[{"start":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T00:00:00Z","timestamp":1569283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2020,2,1]]},"DOI":"10.1080\/21645515.2019.1657753","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T18:11:49Z","timestamp":1566583909000},"page":"327-334","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":16,"title":["The potential public health impact of Herpes Zoster vaccination in the 65 years of age cohort in Italy"],"prefix":"10.1080","volume":"16","author":[{"given":"Antonio","family":"Volpi","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences and Translational Medicine, University of Rome \u201cTor Vergata\u201d, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9695-7549","authenticated-orcid":false,"given":"Sara","family":"Boccalini","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Florence, Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Dari","sequence":"additional","affiliation":[{"name":"NEOS (Neuroscienze, Salute Mentale e Organi di Senso), Sapienza University, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Clarke","sequence":"additional","affiliation":[{"name":"Health Economics Zoster, GSK, Wavre, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7423-0111","authenticated-orcid":false,"given":"Desmond","family":"Curran","sequence":"additional","affiliation":[{"name":"Health Economics Zoster, GSK, Wavre, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Idalba","family":"Loiacono","sequence":"additional","affiliation":[{"name":"ITA Market Access and Pricing, GSK Italy, Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Pitrelli","sequence":"additional","affiliation":[{"name":"ITA Market Access and Pricing, GSK Italy, Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Puggina","sequence":"additional","affiliation":[{"name":"ITA Market Access and Pricing, GSK Italy, Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Tosatto","sequence":"additional","affiliation":[{"name":"ITA Market Access and Pricing, GSK Italy, Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desir\u00e9e","family":"Van Oorschot","sequence":"additional","affiliation":[{"name":"Health Economics Zoster, GSK, Wavre, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1179-4411","authenticated-orcid":false,"given":"Elisabetta","family":"Franco","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, University \u201cTor Vergata\u201d, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2019,9,24]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1586\/erv.10.30"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1302674"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.9.3.361"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268817001546"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2008.03.011"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1264834"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1086\/522152"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462316000337"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-10-230"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp170399"},{"key":"CIT0011","unstructured":"European Centre for Disease Prevention and Control (ECDC). Vaccine scheduler - Herpes Zoster: recommended vaccinations. [accessed 2018 Oct 19]. https:\/\/vaccine-chedule.ecdc.europa.eu\/Scheduler\/ByDisease?SelectedDiseaseId=51&SelectedCountryIdByDisease=\u22121"},{"key":"CIT0012","unstructured":"Gazetta Ufficiale della Republica Italiana. Piano Nazionale Prevenzione Vaccinale 2017\u20132018 (PNPV). 2017 [accessed 2018 Jul 23]. http:\/\/www.gazzettaufficiale.it\/eli\/id\/2017\/02\/18\/17A01195\/sg"},{"key":"CIT0013","unstructured":"Food and Drug Administration. Approval letter - Zostavax. 2018 Mar 21 [accessed 2018 Jul 23]. https:\/\/www.fda.gov\/downloads\/biologicsbloodvaccines\/vaccines\/approvedproducts\/ucm602293.pdf."},{"key":"CIT0014","unstructured":"Merck & Co. Inc. Zostavax (zoster vaccine live) prescribing information. [accessed 2017 Jun 15]. www.merck.com\/product\/usa\/pi_circulars\/z\/zostavax\/zostavax_pi2.pdf"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051016"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu918"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis638"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw047"},{"key":"CIT0019","unstructured":"Food and Drug Administration. Approval Letter - SHINGRIX, 2017. 2017 Oct 20 [accessed 2018 Jul 23]. https:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM581750.pdf"},{"key":"CIT0020","unstructured":"Health Canada. Shingrix product monograph including patient medication information. 2017 [accessed 2018 Dec 6]. https:\/\/pdf.hres.ca\/dpd_pm\/00041658.PDF"},{"key":"CIT0021","unstructured":"Pharmaceuticals and Medical Devices Agency. New drugs approved in FY 2017. 2018 [accessed 2018 Oct 16]. http:\/\/www.pmda.go.jp\/files\/000224507.pdf#page=10"},{"key":"CIT0022","unstructured":"Committee for Medicinal Products for Human Use (EMA - CHMP). Summary of opinion, Shingrix (EMA\/CHMP\/811150\/2017). 2018 [accessed 2018 Oct 16]. https:\/\/www.ema.europa.eu\/documents\/smop-initial\/chmp-summary-positive-opinion-shingrix_en.pdf"},{"key":"CIT0023","unstructured":"Australian Government - Department of health: therapeutic good administration. SHINGRIX recombinant Varicella Zoster virus glycoprotein E antigen vaccine 50 micrograms powder vial and suspension vial for suspension for injection. [accessed 2018 Oct 19]. https:\/\/www.ebs.tga.gov.au\/servlet\/xmlmillr6?dbid=ebs\/PublicHTML\/pdfStore.nsf&docid=5E9F90B4A76B269ACA258304004238C9&agid=(PrintDetailsPublic)&actionid=1"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501184"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603800"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6703a5"},{"key":"CIT0027","unstructured":"National Advisory Committee on Immunization (NACI). An Advisory Committee Statement (ACS): updated recommendations on the use of Herpes Zoster vaccines. 2018 [accessed 2018 Oct 16]. https:\/\/www.canada.ca\/en\/services\/health\/publications\/healthy-living\/updated-recommendations-use-herpes-zoster-vaccines.html"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1345399"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-018-0236-3"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.07.005"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1509645"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1264832"},{"key":"CIT0033","unstructured":"Istat - Istituto Nazionale di Statistica. Statistiche demografiche. [accessed 2018 Jul 23]. http:\/\/demo.istat.it\/pop2017\/index.html"},{"key":"CIT0034","unstructured":"Istat - Istituto Nazionale di Statistica. Tavole di mortalit\u00e0. [accessed 2018 Jul 23]. http:\/\/dati.istat.it\/Index.aspx?DataSetCode=DCIS_MORTALITA1."},{"key":"CIT0035","unstructured":"World Health Organization. WHO database for deaths related to HZ for Italy (ICD10 \u2013 B02 codes). [accessed 2017 Nov 10]. http:\/\/data.euro.who.int\/dmdb\/"},{"key":"CIT0036","volume-title":"Unit costs of health and social care 2016","author":"Curtis L","year":"2016"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2017.7431"},{"key":"CIT0038","first-page":"541","volume":"50","author":"Robert Koch Institut","year":"2018","journal-title":"Epidemiol Bull"},{"key":"CIT0039","unstructured":"Ministero della Salute. Tariffe delle prestazioni di assistenza ospedaliera per acuti, per tipo di ricovero (Euro). 2018 [accessed 2018 Jul 23]. http:\/\/www.trovanorme.salute.gov.it\/norme\/renderPdf.spring?seriegu=SG&datagu=28\/01\/2013&redaz=13A00528&artp=1&art=1&subart=1&subart1=10&vers=1&prog=001"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2019.1657753","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T14:19:52Z","timestamp":1608733192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2019.1657753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,24]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2,1]]}},"alternative-id":["10.1080\/21645515.2019.1657753"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2019.1657753","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-05-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-31","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}